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ABSTRACT 
LONGITUDINAL TRAJECTORIES AND PREDICTORS OF FUNCTIONAL 
IMPAIRMENT IN MILD COGNITIVE IMPAIRMENT, ALZHEIMER’S 
DISEASE, AND VASCULAR DEMENTIA 
SEPTEMBER 2014 
LAUREN ZERANSKI CHISHOLM, B.A., DARTMOUTH COLLEGE 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Rebecca Ready 
Functional disability in older persons with cognitive impairment is associated with 
reduced quality of life and greater mortality, health care utilization, and caregiver burden. 
Episodic memory, executive function, apathy, depressive symptoms, and medical burden 
have been identified as cross-sectional predictors of functional disability but have 
received little longitudinal investigation in a way that explicates how changes in these 
variables relates to functional disability. Functional disability also drives the distinction 
between the diagnoses of Mild Cognitive Impairment (MCI) and dementia; however, 
little is known about the rates of functional decline in these groups over time. This study 
utilized multi-level modeling to determine the longitudinal associations between episodic 
memory, executive function, apathy, depressive symptoms, and medical burden and 
functional decline in older persons with MCI and two of the most prevalent types of 
dementia, Alzheimer’s disease and vascular dementia. Results provide support for the 
longitudinal associations between memory, executive function, and apathy symptoms and 
 v 
instrumental activities of daily living (IADL) performance. Alzheimer’s disease was 
associated with a faster rate of function decline than normal aging and vascular dementia, 
but a rate not significantly different than seen in MCI. Longitudinal decline in IADLs 
was non-significant in both normal aging and vascular dementia. 
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CHAPTER I 
INTRODUCTION 
Due to the aging of the Baby Boomer generation, the number of Americans aged 
65 and older is projected to almost double to 72 million by 2030; the number of 
Americans aged 85 and older also is projected to increase to 19 million from 5.7 million 
by 2050 (Federal Interagency Forum on Aging-Related Statistics, 2010). While efforts 
are underway to develop treatments to prevent cognitive impairment in this population of 
older adults, prevention of premature disability and institutionalization in those who 
develop cognitive impairment remains an important goal. Central to this goal is an 
improved understanding of functional disablement in dementia. Functional disability is 
commonly described in terms of the ability to perform activities of daily living (ADLs). 
These include basic ADLS (BADLs), which are simple self-care activities such as eating, 
bathing, toileting, and dressing that are associated with motor functioning and basic 
visuospatial abilities (Boyle, Cohen, Paul, Moser, & Gordon, 2002; Herlitz, Hill, 
Fratiglioni & Backman, 1995). They also include instrumental ADLs (IADLs), which are 
more complex, adaptive activities that demand higher levels of function. IADLs include 
balancing a checkbook, preparing meals, driving, and using the telephone, and are tied to 
higher-order cognitive processes like organization, judgment, and sequencing of 
attention. 
Impairments in ADLs are associated with a multitude of adverse outcomes for 
persons with dementia, including decreased autonomy and quality of life, increased 
mortality and health care utilization, and greater caregiver burden (Andersen, Wittrup-
Jensen, Lolk, Andersen, & Kragh- Sorensen, 2004; Covinsky, Newcomer, Fox, Wood, 
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Sands, & Dane et al., 2003; Hill, Fillit, Thomas, & Chang, 2006; Razani et al., 2007). 
Functional disability also is associated with increased expense. Greater functional 
dependence raises odds for institutionalization into nursing homes and other long-term 
care settings, at tremendous cost to families and the public welfare sector (Hill et al., 
2006).  
Much of the extant literature on functional disability in dementia has focused on 
cross-sectional relationships between single predictors or classes of predictors (e.g. 
neuropsychiatric or cognitive variables) and functional dependence. There is converging 
evidence for the power of cognition, neuropsychiatric symptoms, and, to a lesser extent, 
medical burden, in predicting functional disability in cognitively impaired older adults. 
Less attention has been directed towards modeling the power of these variables in 
combination and over time for predicting disability. The limited longitudinal research that 
is available has examined the strength of mostly cognitive predictors at baseline in 
determining later functional outcomes (Bennett et al., 2002; Royall, Palmer, Chiodo & 
Polk, 2004). Information on annual rates of change in functional dependence in MCI, 
Alzheimer’s disease, and vascular dementia also is limited. Only one study has used 
advanced statistical methods to estimate the level and annual rate of change in the ability 
to perform IADLs in persons with MCI and dementia (Tomaszewski Farias et al., 2009). 
This study assessed a small sample of participants and warrants replication.  
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CHAPTER II 
LITERATURE REVIEW 
Overview of Functional Disability in Mild 
Cognitive Impairment and Dementia 
Pattern of Decline 
Functional disablement in persons with dementia typically occurs in a progressive 
pattern whereby IADLs decline first, followed by BADLs; however, individual 
variability has been seen in both the rate of decline and the order in which activities 
become compromised (Arrighi, Gelinas, McLaughlin, Buchanan & Gauthier, 2013). 
Performance of complex activities often begins to decline years prior to diagnosis. 
Indeed, transportation and telephone use, and management of finances and medications 
have been found to diverge significantly in predementia subjects from normal controls 
five and six years prior to dementia diagnosis (Amieva et al., 2008). Difficulties in 
driving also have been reported before detectable cognitive impairment in older adults 
(Fields et al., 2010). In contrast, deterioration of BADLs typically occurs in the later 
stages of dementia, when patients become dependent on others for care. After an 
individual becomes dependent in BADLs, he or she may lose the capacity for speech and 
posture (Desai, Grossberg, & Sheth, 2004).  
Typical Levels of Impairment by Diagnosis 
Little normative data exist regarding differences in the extent of functional 
disability in normal cognitive aging, MCI, and dementia subtypes (Rockwood, 2007). 
Historically, diagnostic criteria for MCI stipulated that persons must have essentially 
normal functional abilities; however, cross-sectional research suggests that individuals 
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with MCI demonstrate more functional impairments than persons with normal aging but 
fewer impairments than persons with dementia (Albert, Tabert, Dienstag, Pelton, & 
Devanand, 2002; Aretouli & Brandt, 2010; Brown, Devanand, Liu, & Caccappolo, 2011; 
Farias et al., 2006; Pereira, Yassuda, Oliviera, & Forlenza, 2008; Wadley, Okonkwo, 
Crowe, & Ross-Meadows, 2008; Yeh et al., 2011). Based on this research, recent 
revisions to the MCI diagnostic criteria allow for mild difficulty in IADLs as well as 
some assistance in performing these activities (Morris, 2012). However, the field 
continues to lack consensus on how much functional dependence should be exhibited, 
and in what domains, before a diagnosis of dementia is warranted (Farias et al., 2006; 
Gold, 2012).  
Data regarding differences in functional limitations by dementia subtype also is 
limited and conflicting. Cross-sectional research has described greater limitations in 
BADLs in persons with vascular dementia compared to those with Alzheimer’s disease, 
controlling for medical comorbidities and dementia severity, but no significant 
differences in IADLs (Gure, Kabeto, Plassman, Piette & Langa, 2010). A review of the 
literature on functional impairment in vascular dementia describes functional decline of a 
similar nature, but with a slower trajectory in vascular dementia, than that seen in 
Alzheimer’s disease (Boyle & Cahn-Weiner, 2004), a conclusion replicated recently by 
Gill et al. (2004). More longitudinal research is needed to better understand the course of 
functional decline in vascular dementia and how it compares to changes seen in normal 
aging, MCI, and Alzheimer’s disease, controlling for other predictors of disability. 
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Cognitive Impairments and Functional Disability 
Overall Association Between Cognitive and Functional Impairments 
Functional disability may result from impairments in memory, language, 
visuospatial abilities, planning, organization, and divided attention (Farias et al., 2006). 
Based on a comprehensive review of the literature of the relationship between cognition 
and functional status in older persons with cognitive impairment, Royall and colleagues 
(2007) found that cognitive variables account for a modest proportion (20%) of variance 
in functional outcomes. Global cognitive ability has consistently predicted functional 
outcomes in both cross-sectional and longitudinal research (Bennett et al., 2006; Royall et 
al., 2004). Tests of general cognition including the Mini Mental State Exam, the 
Dementia Rating Scale, the Mattis Dementia Rating Scale, and the Short Portable Mental 
Status Quotient are associated with functional status in dementia patients (Baird, Podell, 
Lovell, & McGinty, 2001; Royall et al., 2007; Tekin, Fairbanks, O’Connor, Rosenberg, 
& Cummings, 2001). This evidence is not surprising given that greater functional 
dependence typically accompanies greater disease severity. Associations between 
specific cognitive domains and functional disability have been studied and show that 
memory and executive functions consistently predict everyday functioning in cognitively 
impaired older adults. 
Memory  
Memory impairment is the hallmark symptom of dementia and of amnestic MCI, 
the most prevalent subtype of MCI that is chiefly characterized by memory decline. 
Episodic memory is memory for information that is personally experienced and is more 
impaired than memory for general information (i.e., semantic memory) in amnestic MCI 
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and AD (Albert et al., 2011; Sperling et al., 2010). Several studies demonstrated cross-
sectional relationships between episodic memory and functional abilities. For example, in 
assisted living residents, a 10-point decline on a word-list verbal learning task predicted a 
6-point decline on a functional impairment measure (Burdick et al., 2002). Another study 
of admissions to a geriatric inpatient unit determined that immediate recall performance 
on a verbal memory test (Logical Memory I, WMS-R; Wechsler, 1987) was significantly 
correlated with scores on a performance-based measure of ADLs, particularly in the 
domains of safety (r = 0.30), money management (r = 0.30), and medication management 
(r = 0.44; Richardson, Nadler, & Malloy, 1995). Verbal memory also has been shown to 
predict 23% of the variance in an informant-rated measure of everyday functioning in a 
large multicultural sample of community-dwelling older adults (Farias, Mungas, Reed, 
Haan, & Jagust, 2004). 
Executive Function 
Executive abilities also are a consistent predictor of functional disability. 
Executive function broadly relates to the regulation of multiple cognitive processes 
including the planning, coordination, and execution of a response, mental flexibility, 
response inhibition and self-monitoring. Due to its conceptualization as the brain’s 
central executive, impaired executive function can result in poor coordination of multiple 
cognitive functions (Cahn-Weiner et al., 2007) and thus impair performance on memory 
or attention tasks. Conversely, intact executive abilities may mediate the effect of 
impairment in other specific cognitive domains, such as memory, on functional status 
(Cahn-Weiner et al., 2007). For instance, the ability to coordinate mental functions, 
sequence attention, and plan and organize behaviors may allow an individual to 
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successfully utilize compensatory strategies, such as notes or to-do lists, and thereby 
reduce the effects of memory impairment on ADLs.  
A review of cognitive predictors of functional status determined that tests of 
executive cognition predict an average of 6.5% of the variance in functional outcome 
measures (Royall et al., 2007). Problems with executive function have been significantly 
associated with IADL limitations in community-dwelling older adults with subclinical 
levels of cognitive impairment (Royall, Chiodo, & Polk, 2000), and baseline executive 
abilities, as measured by a composite scale, have predicted later change in everyday 
function in persons with a range of cognitive functioning, from normal cognitive aging to 
moderate dementia (Cahn-Weiner et al., 2007). 
Working memory may be particularly useful in predicting functional disability 
(Aretouli & Brandt, 2009). Part B of the Trail-Making Test (TMT-B), a commonly used 
test of working memory and set shifting, has predicted everyday functioning in research 
with older adults with a range of cognitive impairment. Scores on the TMT-B accounted 
for 25% of the variance in BADLs and IADLs in a study of assisted living residents 
(Burdick et al., 2005). A similar relationship was found between TMT-B scores and 
performance on IADL items from the Disability Assessment in Dementia in persons with 
amnestic MCI (r = 0.23) and specifically with the planning, organization, and 
performance aspects of these tasks (Yeh et al., 2011). TMT-B scores were highly 
correlated with scores on the Independent Living Scales, an objective measure of ability 
to perform IADLs, in a study of community-dwelling elderly with and without dementia 
(r = -0.71; Bell-McGinty, Podell, Franzen, Baird, & Williams, 2002). 
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Relative Associations of Memory and Executive 
Function with Functional Disability  
Given the consistent associations between episodic memory and executive 
function and functional disability, recent research has attempted to determine their 
relative strengths in predicting everyday functioning in persons with cognitive 
impairment. In a longitudinal study of 106 older adults followed for an average of five 
and a half years, both memory and executive function were associated with baseline and 
longitudinal IADLs, such that poorer performance in both domains correlated with more 
impaired functional status as well as a faster rate of functional decline (Cahn-Weiner et 
al., 2007). However, when both memory and executive function were included in a model 
of longitudinal functional change, the relationship between memory and functional 
decline became non-significant and only executive function predicted functional decline 
over time (Cahn-Weiner et al., 2007). Likewise, a meta-analysis of studies about 
cognition and functional outcomes in older adults with cognitive impairment determined 
that executive function has a stronger association with functional disability than memory, 
and that the association between memory and functional status is attenuated by executive 
function and age, such that its independent contribution is basically non-significant 
(Royall et al., 2007).  
Two studies that examined the longitudinal relationships between change in 
memory and executive function and change in functional abilities provide conflicting 
results. In one study, change in executive function but not memory was independently 
associated with IADL performance (Royall, Palmer, Chiodo, & Polk, 2005). In the other, 
changes in episodic memory and executive functions provided independent and additive 
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contributions to changes in IADLs (Tomaszewki Farias et al., 2009). Thus, it is presently 
unclear whether executive function is a stronger predictor of functional disability or 
whether, controlling for executive function, memory also plays a unique role.  
Neuropsychiatric Symptoms and Functional Disability 
Prevalence of Neuropsychiatric Symptoms in 
Mild Cognitive Impairment and Dementia 
As stated earlier, performance on cognitive testing predicts only a modest 
proportion of the variance in ADLs in persons with cognitive impairment, indicating that 
other variables also predict function (Fischer, Verhoeff, Churchill, & Schweizer, 2009; 
Royall et al., 2007). Empirical support has been provided for the contribution of 
neuropsychiatric, or behavioral, symptoms to functional limitations in MCI and dementia. 
Neuropsychiatric symptoms, as measured by the total score on the Neuropsychiatric 
Inventory (NPI), account for 30% of the variance in IADLs, suggesting that they may be 
as powerful as cognition in predicting functional status in dementia (Tekin et al., 2001).  
Neuropsychiatric symptoms are prevalent in dementia and increase with disease 
severity (Okura et al., 2010). They appear to be equally prevalent among persons with 
Alzheimer’s disease and vascular dementia (Echávarri et al., 2013). A longitudinal study 
of persons with dementia reported five -year prevalence rates of 77% for depression, 71% 
for apathy, and 62% for anxiety, with greatest symptom severity in the apathy domain 
(Steinberg et al., 2008). Neuropsychiatric symptoms also are common in MCI but 
estimates of prevalence are widely variable. One longitudinal study documented a 
prevalence rate of 43% in persons with MCI, with symptoms reaching the level of 
clinical significance in approximately 29% of cases (Lyketsos et al., 2002). Another 
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longitudinal study found that as many as 75% of participants with MCI exhibited at least 
one neuropsychiatric symptom, and 37% endorsed four or more symptoms, with anxiety 
(39%) and depression (35%) the most common (Edwards, Spira, Barnes, & Yaffe, 2009). 
While some neuropsychiatric symptoms may be transient, several symptoms, including 
delusions, depression, apathy, and aberrant motor behavior are likely to persist across 
time (Steinberg et al., 2008).  
Associations with Functional Disability 
As compared to those with minimal symptoms, persons with MCI who have four 
or more neuropsychiatric symptoms evidence greater functional limitations and twice the 
risk for incipient dementia (Edwards et al., 2009). Similarly, the emergence of behavioral 
symptoms in individuals with Alzheimer’s disease has been associated with increasing 
functional limitations (Trachtenberg, Weiner, Patterson, Gamst, & Thal, 2002). The 
presence of three or more neuropsychiatric symptoms, and one clinically significant 
symptom, is associated with higher odds of functional disability in dementia patients 
(Okura et al., 2010). While several studies have analyzed the contribution of non-
cognitive symptoms as a whole or as symptom clusters to functional outcomes, there is 
less research on the independent contributions of specific symptoms. An understanding of 
which neuropsychiatric symptoms are most strongly associated with functional disability 
may encourage health care providers and loved ones to vigilantly monitor for their 
presence and aggressively treat these symptoms to reduce their potentially modifiable 
effects on function. As reviewed below, among neuropsychiatric symptoms, apathy and 
depression are the most consistent cross-sectional predictors of functional disability in 
older adults with cognitive impairment. 
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Depressive Symptoms 
Depressive symptoms are common in MCI and depressive symptoms are 
experienced by approximately 75% of persons with dementia (Edwards et al., 2009; 
Steffens & Potter, 2008). The nature of the relationship between depressive symptoms 
and functional disability remains unclear. It has been suggested that depressive symptoms 
are associated with increased disability due to distress resulting from awareness of one’s 
functional limitations or due to its associations with reduced motivation (Fitz & Teri, 
1994). Alternatively, late life depression and dementia may be driven by the same 
underlying pathology. The pervasiveness of depressive symptoms in persons with 
cognitive impairment has led researchers to hypothesize that depression may be a risk 
factor for dementia, a prodromal stage before impairment, or a part of the same 
pathophysiological process (Barnes et al. 2012; Lyketsos, 2010).  
Depression has independent effects on cognition, such that depressed older adults 
perform consistently worse than non-depressed peers on neuropsychological tests, most 
notably measures of processing speed, acquisition and retrieval of new information, and 
executive functions (Steffens & Potter, 2008). In this way, depressive symptoms can 
exacerbate existing functional impairments in persons with cognitive impairment 
(Hinton, Farias, & Wegelin, 2008). Depressive symptomatology also can provide unique 
contributions to functional disability in dementia. In a sample of persons with 
Alzheimer’s disease, with and without depression, the presence and severity of depressive 
symptoms predicted IADL performance, controlling for cognitive function. Not 
surprisingly, daily functioning was most compromised in participants with severe 
depression (Fitz & Teri, 1994). Similarly, a population-based study of older Italians with 
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very early dementia revealed that depressive symptoms tripled the risk for disability in 
IADLs compared to the diagnosis of early dementia alone (DeRonchi et al., 2005).  
Apathy 
Like depression, apathy is associated with functional disability. Apathy is 
characterized by loss of interest, social withdrawal, and generally decreased motivation, 
initiation, and persistence in the absence of low mood or depressive thought patterns 
(Fones, 1998; Ishii, Weintraub, & Mervis, 2009). In persons with cognitive impairment, 
apathy may be more common than depression, which is characterized by guilt, sad mood, 
hopelessness and poor self-concept (Landes, Sperry, & Strauss, 2005). Estimated 
prevalence rates for apathy in persons with MCI range from 3-60% (Ellison, Harper, 
Berlow, & Zeranski, 2008). It has been estimated to affect 55% of persons with AD and 
70% of persons with mixed AD/vascular dementia in clinical practice (Mulin et al., 
2011). Informant-rated apathy symptoms have been significantly associated with 
impairment in both BADLs and IADLs in dementia clinic outpatients (Clarke et al., 
2008). In a study of persons with vascular dementia, apathy symptoms accounted for 
36% of the variance in total ADL impairment (both BADLs and IADLs), controlling for 
dementia severity (Zawacki et al., 2002).  
Due to the recognition that depression and apathy are not the same construct, 
there is a need to distinguish their independent contributions to daily functioning. Thus 
far, only a few cross-sectional studies addressed this question. In persons with probable 
or possible Alzheimer’s disease, apathy was found to be more common (59.5 %) than 
dysphoria (8.4%) and more strongly related to functional disability (r = 0.57) than 
dysphoria (r = 0.21) (Landes et al., 2005). Another study of 195 community-dwelling 
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Chinese elderly with questionable dementia (comprising MCI and very mild dementia) 
and 95 persons with Alzheimer’s disease found that apathy and depressive symptoms 
were differentially associated with functional abilities in the two groups. Apathy, 
depression, or the combination predicted poorer functional performance in participants 
with questionable dementia. Among participants with Alzheimer’s disease, apathy alone 
predicted poorer functional performance. Specifically, in persons with Alzheimer’s 
disease, apathy was associated with impairments in planning, initiating and executing 
IADLs, while depression only was associated with impaired initiation and planning 
(Lam, Tam, Chiu, & Lui, 2006). Similarly, apathy and not depression has been associated 
with greater functional disability in persons with amnestic MCI (Zahodne & Tremont, 
2013). Additional research is needed to replicate these findings and determine whether 
depression and apathy independently predict functional loss.  
Medical Burden and Functional Disability 
Poor physical health is another established predictor of functional limitations in 
aging. Longitudinal investigations have found that cardiovascular risk factors, including 
hypertension, Type II diabetes, and obesity are associated with greater functional 
limitations in late life (Newman et al., 2009). Lower levels of disease burden are 
associated with recovery from functional limitations (Knoefel & Patrick, 2003; Miller et 
al., 2004). These conclusions largely have been reached through community-based 
studies, and information regarding the relationship between medical disease burden and 
functional abilities in persons with cognitive impairment is limited. One cross-sectional 
study of 143 clinic outpatients with probable or possible Alzheimer’s disease found no 
relationship between overall medical burden and IADL impairment (Tekin et al., 2001) 
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while another study using a larger sample (n= 999) of clinic outpatients and residents of 
assisted living facilities and nursing homes found significant associations between scores 
on a general rating of medical comorbidity and functional impairment (Lyketsos et al., 
1999). In another study of 198 residents of assisted living facilities, the difference 
between excellent and fair health ratings had a comparable association with increased 
functional disability as a 7-point, or 23% drop in score on the Mini Mental State Exam, a 
commonly-used brief assessment of global cognitive impairment (Burdick et al., 2005). 
Clearly, more research is needed to clarify these discrepant findings and determine the 
relationship between medical illness burden and functional disability in persons with 
cognitive impairment. In addition, the relative strength of the relationship between 
medical burden compared to cognitive and neuropsychiatric predictors of disability 
remains an important question.  
The Current Study 
The proposed study expands our understanding of predictors of functional 
disability by examining longitudinal associations between cognitive, neuropsychiatric, 
and medical factors and functional disability in a large outpatient sample of persons aged 
60+ with MCI, Alzheimer’s disease, and vascular dementia from the Massachusetts 
Alzheimer’s Disease Research Center’s Longitudinal Study on Memory and Aging. 
Specifically, the current study determined the longitudinal relationships between episodic 
memory, executive function, apathy, depression, and medical burden and IADLs. In 
addition, the current study provides precise estimation of average annual rates of 
functional change for persons with a given baseline diagnosis (MCI, Alzheimer’s disease, 
or vascular dementia) in comparison to older adult controls.  
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This study adds to the literature in several ways. First, it replicates and attempts to 
resolve contradictions posed by the few prior investigations of the longitudinal 
relationship between cognitive impairment and functional impairment in persons with 
MCI and dementia. Second, it extends these findings by considering other established 
cross-sectional predictors of functional disability in persons with cognitive impairment: 
the neuropsychiatric symptoms of depression and apathy, and general medical burden. In 
so doing, this study adds to our understanding of what factors contribute to functional 
disability in persons with cognitive impairment. Third, the current study measures the 
average level of functional impairment in MCI, Alzheimer’s disease, and vascular 
dementia, as well as the average annual rate of change in persons with these diagnoses. 
This information can help patients, caregivers, and health care providers plan future care 
needs.  
Specific Aims 
Aim 1 
Determine the longitudinal associations between episodic memory, executive 
function, depression, apathy, and medical disease burden and IADLs in a sample of 
persons with baseline diagnoses of Mild Cognitive Impairment, mild to moderate 
Alzheimer’s disease, and vascular dementia.  
Hypotheses 
Episodic memory and executive function will predict everyday function such that 
greater impairments in memory and executive function will be associated with greater 
dependence in IADLs (Royall et al., 2005; Tomaszewski Farias, 2009). In addition to 
memory and executive function, longitudinal changes in depression, apathy, and medical 
 16 
burden will be associated with longitudinal changes in function (Burdick et al., 2005; 
Clarke et al., 2008; De Ronchi et al., 2005; Fitz & Teri, 1994; Lyketsos et al., 1999; 
Zawacki et al., 2002). Increased depression, apathy, and medical burden will predict 
greater dependence in IADLs.  
Aim 2 
Determine the average level of dependence in IADLs in persons diagnosed at 
baseline with MCI, mild to moderate Alzheimer’s disease and vascular dementia, as 
compared to persons with normal cognitive aging.  
Hypothesis 
Persons with MCI will exhibit intermediate levels of IADL dependence, 
compared to persons with normal cognitive aging and persons with dementia, who will 
have the greatest levels of IADL dependence (Albert et al., 2002; Aretouli & Brandt, 
2010; Brown, Devanand, Liu, & Caccappolo, 2011; Farias et al., 2006; Pereira, Yassuda, 
Oliviera, & Forlenza, 2008; Wadley, Okonkwo, Crowe, & Ross-Meadows, 2008). 
Participants with Alzheimer’s disease and vascular dementia will exhibit comparable 
levels of IADL dependence (Boyle & Cahn-Weiner, 2004; Gure et al., 2010). 
Aim 3 
Determine how initial diagnostic status of MCI, Alzheimer’s disease, or vascular 
dementia relates to average annual rate of change in the ability to independently perform 
IADLs, in comparison to normal controls. 
Hypotheses 
Individuals with MCI will evidence slower rates of change in their ability to 
independently perform IADLs than persons with dementia but steeper declines than 
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persons with normal cognitive aging (Albert et al., 2002; Aretouli & Brandt, 2010; 
Brown, Devanand, Liu, & Caccappolo, 2011; Farias et al., 2006; Pereira, Yassuda, 
Oliviera, & Forlenza, 2008; Wadley, Okonkwo, Crowe, & Ross-Meadows, 2008). 
Persons with Alzheimer’s disease will evidence steeper rates of functional decline than 
persons with vascular dementia (Boyle & Cahn-Weiner, 2004; Gill et al., 2013). 
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CHAPTER III 
METHOD 
Participants 
Data from 643 participants of the Massachusetts Alzheimer’s Disease Research 
Center’s (MADRC’s) "Longitudinal Cohort on Memory & Aging" project were used in 
this study. Participants were recruited in several ways. Approximately 10% of the cohort 
was recruited by the MADRC’s Education and Information Transfer Core, through a 
variety of outreach initiatives that include advertisements in minority-targeted 
newspapers and presentations at minority-focused events. Other participants were 
referred from affiliated clinics of the Massachusetts General Hospital (MGH): 18% from 
the MGH Memory Disorders Unit; 10% from the MGH Movement Disorders Unit; and 
approximately 1% from Brigham & Women's Hospital. Nine percent are spouses or other 
caregivers of patients with dementia, and approximately 18% were recruited from the 
MGH Department of Psychiatry's Gerontology Research Unit. Other sources of 
recruitment and enrollment include enrollees in the Nurses' Health study (approximately 
4%) and individuals who participate in the MADRC's clinical trials or other studies. 
Number of study visits ranged from 1-6 (M = 2.4, SD = 1.3). Approximately 35.8% had 1 
visit, 25.8% had 2 visits, 20.2% had 3 visits, 12.8% had 4 visits, 4.2% had 5 visits, and 
1.1% had 6 visits. 
Of the total sample used for this study, at baseline, 271 persons exhibited normal 
cognitive aging (42%), 153 were diagnosed with MCI (24 %), 188 were classified as 
having probable or possible Alzheimer’s disease cases (29%) and 31 were diagnosed with 
vascular dementia (4.8%). Mean baseline global CDR was significantly lower in persons 
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with normal cognitive aging than in persons with MCI, Alzheimer’s disease, and vascular 
dementia. Baseline global CDR scores in these latter groups did not significantly differ 
from each other (Table 2). Those classified as normal cognitive aging at baseline were 
significantly younger than persons diagnosed with MCI, Alzheimer’s disease, and 
vascular dementia (Table 2). There was a significant difference in the gender distribution 
of diagnostic groups: χ2 (3) = 24.47, p < 0.001. Thirty percent of persons with normal 
cognitive aging at baseline were male, compared to 45% of the MCI, 48% of the 
Alzheimer’s disease, and 68% of the vascular dementia groups. Participants had on 
average a college education and there was no significant difference in educational 
attainment between diagnostic groups. Across all diagnostic groups, participants were 
predominantly Caucasian, married or partnered, and living at home with a spouse/partner 
(Table 1).  
Table 1 
 
Descriptive Statistics for Participant Demographics at Baseline by Diagnostic Group 
NCA MCI AD VaD 
(n = 271) (n = 153) (n = 188) (n = 31) 
     
Race 
Caucasian (%) 240 (89) 136 (89) 178 (95) 26 (84) 
African American (%) 29 (11) 11 (7) 9 (5) 4 (13) 
Asian (%) 2 (<1) 6 (4) 1 (<1) 1 (3) 
Hispanica (%) 2 (<1) 2 (1) 3 (2) 1 (3) 
     
Living Situation     
Lives alone (%) 71 (26) 44 (29) 34 (18) 8 (26) 
With spouse/partner (%) 179 (66) 96 (63) 139 (74) 23 (74) 
With relative/friend (%) 16 (6) 9 (6) 11 (6) — 
With group (%) 1 (<1) — — — 
Other/unknown (%) 4 (1.5) 4 (3) 4 (2) — 
     
Marital Status     
Married (%) 180 (66) 97 (63) 139 (74) 23 (74) 
Widowed (%) 35 (13) 36 (24) 27 (14) 1 (3) 
Separated/divorced (%) 27 (10) 12 (8) 10 (5) 4 (13) 
Never married (%) 20 (7) 4 (3) 10 (5) 1 (3) 
Living as married (%) 1 (<1) 1 (<1) 2 (1) — 
Other/unknown (%) 8 (3) 3 (2) — 2 (6) 
     
a
 Hispanic ethnicity coded in addition to race. 
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Table 2 
 
Descriptive Statistics for Model Variables at Baseline 
 
NCA MCI AD VaD 
F (n = 271) (n = 153) (n = 188) (n = 31) 
      
CDR globala 0.28 (0.42) 0.46 (0.58) 0.48 (0.54) 0.48 (0.56) 7.59 (3, 639)** 
FAQa,b,c 0.01 (0.09) 0.30 (0.43) 0.98 (0.95) 0.66 (0.84) 104.52 (3,639)** 
Number medicationsa 4.87 (3.45) 6.09 (4.11) 6.14 (3.27) 7.06 (4.56) 7.63 (3, 639)* 
Trail-Making Test Bb,c,d 82.26 (64.81) 148.28 (121.30) 233.21 (264.83) 148.35 (176.84) 30.95 (3,639)** 
WMS-R Logical Memory IIa 13.41 (3.38) 8.22 (4.33) 6.16 (6.14) 10.58 (5.94) 97.29 (3,639)** 
NPI-Q Depressiond 0.12 (0.37) 0.34 (0.65) 0.27 (0.56) 0.37 (0.62) 7.50 (3, 639)** 
NPI-Q Apathyb,c 0.03 (0.17) 0.14 (0.44) 0.39 (0.69) 0.23 (0.50) 23.34 (3,639)* 
GDSd 0.94 (1.61) 1.97 (2.03) 1.78 (1.92) 2.07 (1.60) 14.60 (3,639)** 
Agea 72.73 (7.00) 77.49 (6.64) 77.63 (6.92) 77.45 (8.48) 25.08 (3,639)* 
Education 16.31 (2.45) 15.73 (2.95) 15.96 (3.31) 16.29 (2.94) 1.5 (3,639) 
Gender (% male) 30 45 48 65  
      
 
a In posthoc tukey pairwise comparisons, NCA mean was significantly different from all other means (p < 0.001). 
b In posthoc tukey pairwise comparisons, MCI mean was significantly different from AD mean (p < 0.001). 
c In posthoc tukey pairwise comparisons, AD mean was significantly different from VaD mean (p = 0.01). 
d In posthoc tukey pairwise comparisons, NCA mean was significantly different from MCI mean (p < 0.001). 
*p < .001. **p < .0001. 
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Measures 
Functional Assessment 
Functional disability was measured by the Functional Activities Questionnaire 
(FAQ; Pfeffer, Kurosaki, Harrah, Chance, & Filos, 1982; Appendix A). The FAQ is a 10-
item questionnaire that assesses a patient’s independence in IADLs including paying 
bills, preparing a balanced meal, remembering appointments, etc. Questions can be 
scored from 0-3, with 0 = normal or intact abilities; 1= some difficulty but independent; 2 
= requires assistance, and 3 = dependent. Higher scores indicate greater disability. The 
rater also can record which activities the patient never performed. To adjust for items that 
the participant never performed, the mean FAQ item score for each participant was used 
in the current study to represent IADL disability, rather than the sum of scores for all 
items. Thus, while total scores on the FAQ can range from 0-30, the possible range for 
the outcome variable in the current study is 0-3 (the score range for an individual item). 
The FAQ is clinician-rated based on informant report and has demonstrated high inter-
rater reliability (r = 0.80 - 0.97; Pfeffer et al., 1982). The assessment has demonstrated 
adequate sensitivity (0.85) and specificity (0.81) in distinguishing cognitively normal and 
impaired older adults (Pfeffer et al., 1982). Previous analysis of data from the National 
Alzheimer’s Coordinating Centers (NACC) found that the FAQ distinguishes between 
persons with MCI and very mild Alzheimer’s disease with 80.3% sensitivity, 87% 
specificity, and 84.7% accuracy (Teng, Becker, Woo, Knopman, Cummings, & Lu, 
2010). Cronbach’s alpha for the 10 FAQ items in the current study sample was 0.90, 
indicating excellent internal consistency. 
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Episodic Memory 
Episodic memory was measured by the Logical Memory II test (Story A) from the 
Wechsler Memory Scale- Revised (WMS-R; Wechsler, 1987; Appendix D). The Logical 
Memory II test from the WMS-R (Wechsler, 1987) measures episodic memory via 
delayed recall of a short story that is read to the examinee. This test is routinely given to 
all MADRC study participants at each study visit. The delayed recall score of Logical 
Memory was chosen because it is considered a reliable measure of episodic memory that 
is highly convergent with other verbal learning tests (Lezak, Howieson, & Loring, 2004). 
Internal consistency reliability for WMS-R Logical Memory II has been estimated at r = 
0.75, inter-rater reliability was estimated to be high (r = 0.97), and test-retest reliability 
for persons aged 65-74 was estimated to range from r = 0.78 - 0.85 (Wechsler, 1987). 
The WMS-R Logical Memory test demonstrated sensitivity in discriminating persons 
with neurological deficits from those without, including persons with dementia 
(Wechsler, 1987). 
Executive Function 
Executive function was represented by performance times on part B of the Trail-
Making Test (TMT; Reitan & Wolfson, 1993; Appendix E). Part A (TMT-A) requires the 
examinee to rapidly connect numbers 1-25 in order and is a test of visual scanning and 
mental processing speed motor and visual processing speed. Part B (TMT-B) represents 
added complexity in that it is comprised of numbers and letters and requires the examinee 
to connect the numbers and letters in order from lowest number, to first letter, to the next 
number and the next letter (1-A-2-B-3-C) and so on. As such, part B is a test of 
sequencing, set-shifting, and mental flexibility (Arbuthnott & Frank, 2000; Reitan & 
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Wolfson, 1993). A review of the available literature suggests that the TMT has adequate 
test-retest reliability and high inter-rater reliability; TMT-B has demonstrated construct 
validity through convergence with several executive functions including executive 
control, cognitive flexibility, and set switching (Strauss, Sherman, & Spreen, 2006). 
Performance on the TMT-B has demonstrated ecological validity in predicting IADL 
performance in older adults and is sensitive to neurological deficits including dementia 
(Cahn-Weiner, Boyle, & Malloy, 2002; Bell- McGinty et al., 2002; Strauss, Sherman, & 
Spreen, 2006).  
Neuropsychiatric Symptoms 
Depression and apathy were measured by the NPI-Q (Kaufer et al., 2000; 
Appendix B), a brief questionnaire form of the Neuropsychiatric Inventory (NPI). The 
NPI-Q has high convergent validity (r = 0.91) with the NPI (Kaufer et al., 2000). The 
NPI-Q is designed to be self-administered to an informant, who is asked about the 
presence over the past four weeks of each of twelve neuropsychiatric symptoms: 
delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, 
euphoria/elation, apathy/indifference, disinhibition, irritability/lability, aberrant motor 
behavior, nighttime disturbances, and appetite/eating changes. If the informant endorses a 
symptom, he/she then rates whether the symptom is mild (1 point), moderate (2 points), 
or severe (3 points). NPI-Q item score can thus range from 0-3, and total score can range 
from 0-36, with higher numbers indicating greater presence of neuropsychiatric 
symptoms. Test-retest reliability for the NPI-Q symptom is adequate (r =.80; Kaufer et 
al., 2000). In order to examine the specific associations between depression and apathy 
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and functional disability, NPI-Q total score was not used in this study. Instead, scores on 
the apathy and depression items from the NPI-Q were extracted for analyses.  
Self-reported depressive symptoms, as measured by the Geriatric Depression 
Scale (15-item version; Sheikh & Yesavage, 1986; Appendix C) also were included to 
determine whether informant-reported and self-reported depressive symptoms are 
differentially associated with functional disability. The GDS-15 is a 15-item measure 
intended for older adults that assesses self-reported depressive symptoms and is routinely 
administered to all MADRC participants as part of the UDS. Questions assess the 
presence of symptoms in the past week, and are answered in a dichotomous yes/no 
format. One point is given for each depressive symptom endorsed, for a total score range 
of 0-15. Analysis of the psychometric properties of the GDS-15 suggest that it has 
moderate internal consistency reliability, adequate criterion validity between depressed 
and non-depressed older persons, and acceptable construct validity with other indicators 
of depression including depressed mood, life satisfaction and suicidal ideation (Friedman, 
Heisel, & Delavan, 2005). Internal consistency and construct validity were similar for 
community-dwelling elders with high and low functional dependence (Friedman, Heisel, 
& Delavan, 2005). Cronbach’s alpha for the GDS-15 in this study sample was 0.73, 
indicating acceptable internal consistency.  
Medical Burden 
Medical burden was represented by the sum of prescription medications used at 
each visit. Over-the-counter medicines and vitamins/supplements were not included in 
the count. Simple medication counts reliably predict health care cost and utilization, 
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hospitalizations, and mortality in older adult outpatients, and compare favorably to other, 
more complex assessments of medical comorbidity (Perkins et al., 2004).  
Procedure 
Approval from the Partners Healthcare Institutional Review Board (IRB) was 
granted before analysis of de-identified patient data from the Massachusetts Alzheimer’s 
Disease Research Center (MADRC). 
MADRC Data Collection 
A Uniform Data Set (UDS), as required by the NIH/NIA for all federally funded 
Alzheimer's Disease Centers (ADCs), is collected from each participant, and data are 
stored locally in the ADRC database, as well as routinely submitted electronically to the 
National Alzheimer's Coordinating Center (NACC) (www.alz.washington.edu) data 
repository. The UDS was first collected by all ADCs on September 1, 2005. Subjects are 
seen approximately every 12 months. The initial visit must be an in-person visit, but 
follow-up visits may be in-person (preferred) or via the telephone. Cognitive testing is 
not administered during telephone follow-up visits. Participants are strongly encouraged 
to bring an informant to the study visit. Each study visit may last from 1.5 to 2 or more 
hours. During each visit, both participants and informants are assessed/interviewed by the 
study doctor, and during in-person visits, the participant is also administered a series 
of neuropsychological tests by a trained research assistant. Some of the UDS forms are 
completed by the study doctor but other UDS forms are completed by the research 
assistant. During the initial study visit, the following data are collected: participant sex, 
age (derived from month & year of birth); race; education; living situation; marital status, 
health history and current medications. If an informant is present, he or she is asked about 
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his/her relationship to the participant. If the informant does not live with the participant, 
the frequency of the informant's visits/telephone calls to the participant is assessed. This 
data is updated at each visit as necessary/appropriate. 
Participants receive a brief physical exam at each study visit, are rated on the 
Unified Parkinson’s Disease Rating Scale - Motor Exam, and are assigned a value on the 
Hachinski Ischemic Score scale, a measure of vascular disease risk. In addition, the 
following information is collected at each visit: participant score on the Clinical 
Dementia Rating Scale (CDR); score on the Geriatric Depression Scale (GDS), 
informant-reported score on the Neuropsychiatric Inventory Questionnaire (NPI-Q); and 
score on the Functional Activities Questionnaire (FAQ). In addition, the following 
cognitive tests are administered as part of the UDS: Mini Mental State Exam (MMSE); 
Logical Memory I & II, Story A from the Wechsler Memory Scales, Revised Edition 
(WMS-R, 1987); Digit Span Forward and Backward; Trail-Making Test A and B; Digit-
Symbol Coding from the Wechsler Adult Intelligence Scale, Revised edition (WAIS-R); 
Category Fluency (Animals); and 30 odd-numbered items from the Boston Naming Test 
(BNT). Based on the clinical interview, the study doctor assigns a diagnosis to each 
participant at each visit. Diagnoses related to Alzheimer’s disease are made according to 
criteria established by the National Institute of Neurological and Communicative 
Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association 
(NINCDS-ADRDA; McKhann et al., 1984). Diagnoses of vascular dementia are arrived 
at according to criteria established by the National Institute of Neurological Disorders 
and Stroke and the Association Internationale pour la Recherché et l'Enseignement en 
Neurosciences (NINDS-AIREN; Roman et al., 1993). 
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Analyses 
Construction of Hierarchical Linear Models 
Trajectories of longitudinal change were estimated using Hierarchical Linear 
Modeling (HLM; Bryk & Raudenbush, 1987), a multi-level modeling technique that 
predicts change over time within individuals as well as the variability in individual 
trajectories over time. Longitudinal analysis in HLM is conceptualized as a two-level 
model, wherein each participant’s development is modeled as an individual growth 
trajectory plus random error at level 1 (within person change over time) and level 2 
represents a between–person model that represents inter-individual differences in change. 
Dependence in IADLs over time, as measured by mean FAQ item score, was the primary 
outcome variable. Memory, executive function, depression, apathy, and medical burden 
were treated as time-varying covariates and entered at level 1. Baseline diagnosis of 
normal cognitive aging, MCI, Alzheimer’s disease or vascular dementia was considered a 
time-invariant covariate at level 2. Because they are known to be associated with 
functional impairment, age (Benke et al., 2013; Millán- Calenti, 2010), gender (Benke et 
al., 2013; Maddox & Clark, 1992; Millán- Calenti, 2010), and level of education 
(Maddox & Clark, 1992), were included as time-invariant controls and also entered at 
level 2.  
Model building began with an unconditional growth model to determine if there 
was significant change in functional disability in IADLs over time, whether change in 
IADLs was linear or curvilinear, and whether there was significant variability in that 
change across individuals. This model served as a baseline model against which 
subsequent models were compared. Level 1 of the model represents an individual’s (j’s) 
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repeated measures of mean FAQ item score (y) across study visits (VISITNUM; from 1 
to i). The intercept β0j represents person j’s expected value of y at study entry or baseline, 
and slope β1j represents the expected linear rate of change in person j’s mean FAQ item 
score as a function of time. Level 2 of the model estimates the average growth trajectory 
across individuals, and indicates whether there is individual variation in trajectory 
intercepts (β0j) and slopes (β1j) where γ represents the average intercept (γ00 ) and slope 
(γ10) and u represents the individual j’s deviations from the average intercept (u0j ) and 
average slope
 
(u1). 
Unconditional Model 
Level 1 
FAQij = β0j + β1j*(VISITNUMij) + rij  
Level 2 
β0j = γ00 + u0j 
β1j = γ10 + u1j 
Model Conditioned on Cognitive, Neuropsychiatric, and Medical Predictors 
Next, five models were built, one each to include five other level 1 predictors that 
were expected to themselves change across time and explain variation in mean FAQ item 
scores over time. These predictors (i.e., episodic memory, executive function, depression, 
apathy, and medical burden) were treated as time-varying covariates. Each predictor was 
grand-mean centered and entered individually into the unconditional level 1 model to 
determine its relationship with mean FAQ item score over time. After these five separate 
models were run, one for each time-varying covariate, variables that showed a significant 
relationship with mean FAQ item score over time were included together at level one in a 
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final, conditional level 1 model. The conditional level 1 model allowed for random 
effects to capture between-person variability in mean FAQ item score and apathy and 
depressive symptom scores. It did not allow for random effects in memory and executive 
function scores because univariate testing did not provide evidence for significant 
variability across groups in the longitudinal relationships between these variables and 
mean FAQ item score. This conditional level 1 model also served as the basis for 
checking the HLM assumptions of homoscedasticity, linearity, independence, and 
normality.  
Model Conditioned on Baseline Diagnostic Status 
A third model was built to determine the average level of functional disability by 
initial diagnostic status (normal cognitive aging, MCI, Alzheimer’s disease, and vascular 
dementia; diagnosis was treated as a time-invariant predictor at level 2), as well as the 
average annual rate of change in mean FAQ item score for each group. Models allowed 
for random effects to capture between-person variability in baseline and longitudinal 
mean FAQ item scores. Persons with MCI, Alzheimer’s disease, and vascular dementia 
were compared to the reference group of persons with normal cognitive aging. 
Hypothesis tests were then performed to separately compare persons with MCI, 
Alzheimer’s disease, and vascular dementia to each other, e.g., MCI to vascular 
dementia, vascular dementia to Alzheimer’s disease, etc. Additional time-invariant 
predictors including age, gender, and level of education were entered at level 2, one at a 
time into this model to determine whether they should be included as control variables; a 
variable that did not explain significant variability in mean FAQ item score was omitted 
from the final model.  
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CHAPTER IV 
RESULTS 
Descriptive Statistics 
Descriptive analyses revealed significant differences in diagnostic groups on 
baseline measures (Table 2). Persons with normal cognitive aging took fewer prescription 
medications than persons with MCI. Performance on Part B of the Trail-Making test was 
significantly faster in persons with normal cognitive aging compared to those with MCI, 
indicating that they were less taxed by this complex task. Persons with Alzheimer’s 
disease performed significantly slower on Part B of the Trail-Making test than all other 
groups. Persons with normal cognitive aging performed significantly better on the 
memory test than persons with MCI, who themselves performed better than persons with 
Alzheimer’s disease. Persons with vascular dementia also performed better on the 
memory test than persons with Alzheimer’s disease. 
Similar patterns were seen in baseline measures of neuropsychiatric symptoms. 
Persons with normal cognitive aging evidenced significantly fewer depressive symptoms 
than persons with MCI on the NPI-Q and the GDS. They also exhibited significantly less 
apathy than persons with MCI, who as a group exhibited significantly less apathy at 
baseline than persons with Alzheimer’s disease. Both informant and self-reported 
neuropsychiatric symptoms were minimal across all diagnostic groups. 
Most of the study variables at the baseline visit were significantly inter-correlated 
(Table 3). Higher mean FAQ item scores were associated with poorer performance on 
cognitive tests and higher ratings for depressive symptoms and apathy. Contrary to 
prediction, number of prescription medications, an indicator of medical burden, only 
 31 
shared significant correlations with scores with depressive symptoms (both GDS and 
NPI-Q) and executive functions, not with daily functioning. A small but significant 
correlation was found between mean baseline FAQ item score and age (r = 0.22, p = 
0.01).  
Table 3 
 
Correlation Matrix for Model Variables  
 1 2 3 4 5 6 7 
        
1. FAQ — .57** −.63** −.63** .52** .11* .09 
2. Trail Making Test B  — −.44** .11** .25** .10* .29** 
3. WMS-R Logical Memory II   — −.14** −.37** −.02 −.06 
4. NPI-Q Depression    — .34** .09** .21* 
5. NPI-Q Depression     — .14** .06 
6. Number Medications      — .15 
7. GDS       — 
        
 
**p < .01. *p < .05. 
Results of Hierarchical Linear Models 
Longitudinal Change in Functional Disability 
Results of the unconditional model, which included all diagnostic groups and no 
predictors other than time, yielded a significant linear effect of time, indicating that on 
average, participants’ mean FAQ item scores increased by 0.06 from one year to the next, 
p < 0.001 (Table 4). That is, overall functional abilities significantly declined over time. 
This model also revealed significant individual variability in the linear rate of change in 
functional disability, χ2(422) = 978.49, p < 0.001, which suggests that some participants 
declined faster than others. Indeed, some persons may have experienced no change in 
their level of functional dependence and some may have become less dependent over 
time (see Figure 1 for an illustration of the mean trajectories of change for each 
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diagnostic group). This individual variability provides support for further examination of 
predictors of variation in trajectories of functional disability. 
Table 4 
 
Model of Change in Functional Disability (Unconditional model) 
Fixed effect  Coefficient SE t 
 Approx. 
df  p 
      
Mean initial status 0.03 0.02 11.22 640 <.001 
Mean growth rate 0.06 0.01 5.65 640 <.001 
      
Random effect SD 
Variance 
component df χ2 p 
      
Initial status 0.55 0.30 422 993.83 <.001 
Growth rate 0.16 0.03 422 978.49 <.001 
Level-1, e 0.25 0.06    
      
 
 
Figure 1. Mean longitudinal trajectories in mean FAQ item score by baseline diagnosis. 
Variation by Cognitive Function, Neuropsychiatric Symptoms, and Medical Burden 
Episodic memory, executive function, and depressive and apathy symptom scales 
from the NPI-Q significantly improved the fit of the unconditional model and 
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significantly predicted functional disability over time1 (Table 5). Inclusion of the number 
of prescription medications taken by participants did not improve the model fit and 
therefore was not included in the final conditional level 1 model. Self-reported depression 
symptomatology, as measured by the GDS, was not included for the same reasons. When 
these four variables were included together in the final conditional level 1 model, 
depressive symptoms (as measured by the NPI) no longer significantly predicted 
functional disability over time.  
Table 5 
 
Conditional Model of Change in Functional Disability  
Fixed effect  Coefficient SE t 
 Approx. 
df  p 
      
Mean initial status 0.31 0.22 13.72 640 <.001 
Mean growth rate 0.033 <0.01 3.70 640 <.001 
Memory slope −0.04 <0.01 −15.47 1518 <.001 
Executive function slope <0.001 <0.001 13.40 1518 <.001 
Apathy slope* 0.31 0.04 7.63 640 <.001 
      
Random effect SD 
Variance 
component df χ2 p 
      
Initial status 0.37 0.13 11 28.37 <.010 
Growth rate 0.09 <0.01 11 49.16 <.001 
Apathy slope 0.32 0.10 11 32.94 <.001 
Level-1 0.28 0.08    
      
 
Note. This model did not allow for random effects for memory or executive function. 
Results from the final conditional level 1 model indicate that, controlling for 
executive function and apathy symptoms, there was a 0.04 increase in mean FAQ item 
score for every one-unit decrease in memory test performance. This suggests that 
episodic memory performance is inversely related to functional disability; for the average 
                                                 
1
 When the ratio of performance times on Trails A divided by Trails B was used 
to represent executive function, the ratio did not significantly predict functional 
disability. 
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participant, worse memory performance predicts greater functional disability. There was 
a significant positive relationship between executive function and functional disability, 
such that mean FAQ item score increased by less than 0.001 for every one second 
increase in completion time on part B of the Trail-Making test, controlling for memory 
test scores and apathy symptoms. There also was a significant positive relationship 
between apathy symptoms and functional disability; controlling for memory and 
executive function, mean FAQ item score increased by 0.31 for every one unit increase 
on the apathy scale of the NPI-Q. Thus, greater apathy and executive dysfunction were 
associated with greater functional impairment. 
Univariate models indicated that there was no significant individual variation in 
the slopes of the associations between longitudinal episodic memory and executive 
function performance and functional disability, indicating that the association between 
these variables and functional disability is similar for all participants. Estimation of 
variance components from the final conditional level 1 model reveals significant 
variability in the slope of the relationship between longitudinal apathy symptoms and 
functional disability. Therefore, controlling for memory and executive function, the 
relationship between apathy symptoms and everyday functioning is different across 
participants. 
Examination of Baseline Age, Gender, and Level of Education 
Participant age at study entry, gender, and level of education were added to the 
model at level 2 to see whether they were associated with participants’ baseline and 
longitudinal levels of functional disability. Gender was entered as an un-centered variable 
and age and education were grand mean centered. Education did not significantly predict 
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disability or improve the model fit and was excluded from the model. Baseline age and 
gender emerged as significant predictors of disability, improved the model fit, and were 
retained in the final model. However, in the conditional model that included age, gender, 
and baseline diagnostic groups, gender no longer significantly predicted mean FAQ item 
score at baseline; t (635) = 1.28, p = 0.20. Gender also no longer predicted longitudinal 
rate of change in functional disability; t (635) = -0.54, p = 0.59. Age continued to predict 
both mean FAQ item score at baseline [t (635) = 2.73, p < 0.01] and longitudinal 
trajectories of functional decline [t (635) = -2.39, p = 0.02].  
Baseline Levels of Functional Disability by Diagnostic Status 
Baseline mean FAQ item score for the entire sample ranged from 0-3, with a 
mean of 0.40 (SD = 0.73). Mean FAQ item score at baseline was significantly different 
between diagnostic groups: F (3,639) = 104.502, p < 0.0001 (Table 2).  
Functional disability at the baseline study visit was estimated for each diagnostic 
group using the intercept for each group from the level 2 model (Table 6). The values for 
persons with MCI, Alzheimer’s disease and vascular dementia represent the difference in 
their baseline scores from the intercept for persons with normal cognitive aging, who 
were selected as the reference group. Participant gender and age at baseline were 
controlled. After controlling for gender and age, mean baseline FAQ item score for a 
person with normal cognitive aging was 0.04, suggesting no appreciable functional 
disability in this group at baseline (Table 6). As expected, persons with MCI exhibited a 
baseline level of functional disability significantly greater than persons with normal 
aging. Mean FAQ item scores were significantly higher at baseline for persons with 
Alzheimer’s disease and vascular dementia than for normal controls. 
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Table 6 
 
Baseline Levels of and Rates of Change in Functional Disability by Baseline Diagnosis 
Fixed effect  Coefficient SE t 
 Approx. 
df  p 
      
Baseline levels normal aging 0.04 0.04 1.01 635 .31 
Mild cognitive impairment 0.13 0.06 2.09 635 .04 
Alzheimer’s disease 0.68 0.06 11.22 635 <.001 
Vascular dementia 0.42 0.12 3.34 635 <.001 
      
Rates of change      
Normal aging <0.001 0.02 0.18 635 .86 
Mild cognitive impairment 0.10 0.03 3.68 635 <.001 
Alzheimer’s disease 0.14 0.03 5.36 635 <.001 
Vascular dementia 0.09 0.06 1.41 635 .16 
      
 
Note. All means are adjusted for age. 
Participants with baseline diagnoses of MCI, AD, and vascular dementia also 
were compared to each other through hypothesis testing in HLM. Mean baseline FAQ 
item score for persons with MCI was significantly different from that for persons with 
vascular dementia; χ2(1) = 4.65, p = 0.03. Baseline diagnosis of AD also was associated 
with a significantly higher mean FAQ item score than for MCI, χ2 (1) = 61.86, p < 0.001. 
A baseline diagnosis of AD also was associated with a significantly higher mean baseline 
FAQ item score than a diagnosis of vascular dementia; χ2(1) = 4.26, p = 0.04. Residuals 
for the level 1 and level 2 data files were checked and indicated that the data do not 
violate the assumptions of linearity, homoscedasticity, independence and normality (see 
Figures 2 and 3).  
Longitudinal Trajectories of Functional Disability by Baseline Diagnostic Status 
The ability to perform IADLs did not change significantly over the course of the 
study in persons with baseline status of normal cognitive aging, controlling for baseline 
age and gender (Table 6). Longitudinal trajectories of functional disability did not differ  
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Figure 2. Level 1 residual plot. 
 
Figure 3. Level 2 residual plot. 
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significantly between persons with normal aging and persons diagnosed with vascular 
dementia. Trajectories of functional decline also did not significantly differ in persons 
with vascular dementia and MCI; χ2 (1) = 0.07, p >0.50. Compared to persons with 
baseline status of normal cognitive aging, persons with baseline diagnoses of MCI and 
Alzheimer’s disease experienced significantly greater impairment in function over time. 
FAQ score increased by 0.10 annually for persons with MCI and 0.14 for persons with 
Alzheimer’s disease, controlling for baseline age and gender. Change in functional 
disability over time was not significantly greater in persons with Alzheimer’s disease 
compared to persons with MCI; χ2 (1) = 1.63, p = 0.20. Trajectories of functional change 
also were not significantly steeper in persons with Alzheimer’s disease compared to those 
with vascular dementia; χ2 (1) = 0.84, p > 0.50. 
Summary of Results 
In summary, episodic memory, executive function, and apathy symptoms 
independently predicted longitudinal decline in complex activities of daily living, 
consistent with a priori hypotheses. Contrary to expectations, depressive symptoms and 
medical burden did not predict longitudinal disability. Persons with a baseline diagnosis 
of MCI exhibited a baseline level of functional disability that was intermediate to persons 
with baseline classifications of normal aging and dementia, as expected. Also expected 
were the significantly steeper trajectories of longitudinal functional decline in MCI and 
Alzheimer’s disease compared to those seen in persons with normal aging at baseline. 
The lack of significant difference in longitudinal rates of functional change in MCI and 
Alzheimer’s disease was an unexpected finding. In the current study, persons with 
Alzheimer’s disease exhibited significantly greater baseline functional disability than 
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persons with vascular dementia, a finding that ran counter to expectations. Longitudinal 
trajectories of disability in vascular dementia also were significantly flatter than in 
Alzheimer’s disease. While a slower rate of decline in vascular dementia compared to 
Alzheimer’s disease was expected, it was not expected that longitudinal decline of 
functional abilities in persons with vascular dementia would not differ significantly from 
persons with baseline classification of normal aging.  
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CHAPTER V 
DISCUSSION 
This is the first study to simultaneously model the longitudinal relationships 
between cognitive, neuropsychiatric, and medical predictors and functional disability. 
This study also adds to the literature by separately comparing longitudinal rates of 
functional decline in normal aging, MCI, and the two most common types of dementia, 
Alzheimer’s disease and vascular dementia. Results from this study suggest that memory 
and executive function independently predict change in complex activities of daily living 
over time. Results also suggest that symptoms of apathy but not depression predict 
longitudinal functional decline. Further, this study reveals that complex activities of daily 
living decline faster in MCI and Alzheimer’s disease than in normal aging and vascular 
dementia, and that these groups exhibit comparable rates of decline. A surprising finding 
was the lack of significant longitudinal functional decline in vascular dementia.  
Baseline Levels of Functional Disability by Diagnostic Group 
Comparisons of baseline and longitudinal levels of functional disability between 
persons with normal cognitive aging and those diagnosed with MCI, Alzheimer’s disease, 
and vascular dementia partially support prior research. Normal cognitive aging was 
associated with a minimal level of dependence at baseline and no significant change over 
the course of the study, as expected. Persons with MCI demonstrated a level of baseline 
disability that was greater than persons with normal aging and less than dementia, 
consistent with previous findings and conforming to diagnostic conventions (Albert et al., 
2002; Aretouli & Brandt, 2010; Brown, Devanand, Liu, & Caccappolo, 2011; Farias et 
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al., 2006; Pereira, Yassuda, Oliviera, & Forlenza, 2008; Wadley, Okonkwo, Crowe, & 
Ross-Meadows, 2008).  
Contrary to expectations, dementia groups did not exhibit comparable levels of 
functional disability at baseline. Diagnosis of Alzheimer’s disease was associated with 
the greatest level of dependence at baseline. The finding that vascular dementia was 
associated with less functional dependence than Alzheimer’s disease is surprising, given 
prior research documenting comparable levels of dependence in these groups (Boyle & 
Cahn-Weiner, 2004; Gure et al., 2010). In this study, persons with vascular dementia 
performed better on tests of memory and executive function than persons with 
Alzheimer’s disease, indicating less impairment on key predictors of everyday 
functioning. Memory and executive function in persons with vascular dementia were 
more similar to persons with MCI in this study, and perhaps commensurately, so was 
their performance on complex ADLs. In addition to their stronger cognitive testing 
performance, methodological reasons may underlie the significantly lower level of 
baseline functional disability in vascular dementia compared to Alzheimer’s disease. It is 
possible that the small size of the vascular dementia sample did not allow for optimal 
estimation of disability levels in this group, particularly considering the variability seen 
in their FAQ scores and the heterogeneous nature of the diagnosis itself.  
Longitudinal Trajectories of Functional Disability by Diagnostic Group 
Longitudinal trajectories of change in functional disability were different between 
groups. As expected, functional disability in persons with MCI progressed at a faster rate 
than in persons with baseline classification of normal aging. Surprisingly, longitudinal 
rates of change in functional disability were not significantly different in MCI and 
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Alzheimer’s disease. In this study, the average score on an item of the FAQ for persons 
with MCI increased by one tenth of one point annually, controlling for age. This 
measurement represents the annual rate of change in any surveyed IADL for the average 
person with MCI.  
The comparable rate of functional decline in MCI and Alzheimer’s disease 
contradicts results from one prior longitudinal study that measured intermediate rates of 
functional decline in persons with MCI compared to persons with normal aging and 
dementia (Tomaszewski Farias et al., 2009). There are several possible explanations for 
this discrepancy. The current sample is comprised of persons from both clinic and 
community sources compared to Tomaszewski Farias’s (2009) clinic-based sample and 
indeed participants in this study were less functionally impaired at baseline than 
participants in the other. Further, it is arguable that IADL items from the Blessed Roth 
Dementia Rating Scale, the measure of functional disability used by Tomaszewski Farias 
(2009), are less complex than IADLs included in the FAQ and therefore less sensitive to 
annual change in less impaired persons, such as those with MCI. For example, IADL 
items on the Blessed Roth include “tendency to dwell in past” and “find way about 
indoors” and “interpret surroundings” whereas IADLs included on the FAQ include 
“playing a game of skill” and “writing checks, paying bills, or balancing a checkbook.” 
Viewed in this way, it is understandable how rates of functional change measured by the 
FAQ in persons with MCI in the current study might be more similar to persons with 
dementia than rates of change measured by the Blessed Roth. 
Alternatively, it is possible that longitudinal rates of functional decline did not 
significantly differ in persons with baseline diagnoses of MCI and Alzheimer’s disease 
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because the majority of persons with Alzheimer’s disease in this study were in the mild 
stages of disease. While baseline FAQ scores were significantly different in MCI versus 
Alzheimer’s disease, baseline CDR scores were not significantly different in these 
diagnostic groups. Mean baseline CDR scores for the Alzheimer’s disease group 
represents a very mild stage of disease that may not be qualitatively different from MCI. 
Another surprising finding was the lack of significant longitudinal functional 
decline in vascular dementia compared to persons with normal aging. As stated 
previously, the small size of the vascular dementia sample may have limited statistical 
power to detect group differences. It also is possible that the time course of the study was 
insufficient to detect functional decline in vascular dementia. Past research indicates that 
functional decline in vascular dementia progresses at a slower rate than in Alzheimer’s 
disease (Boyle & Cahn-Weiner, 2004; Gill et al., 2013). In addition, vascular dementia 
caused by large infarcts, as opposed to cumulative small vessel disease, may progress in a 
step-wise function and as such, significant changes in everyday function may not be 
visible over the short-term (Boyle & Cahn-Weiner, 2004); unfortunately, more data about 
subtypes of vascular dementia for participants in this study were not available.  
Longitudinal Predictors of Functional Disability 
Examination of the longitudinal relationships between cognitive, neuropsychiatric 
and medical variables and everyday functioning revealed that cognitive performance and 
apathy symptoms, and not depression or medical comorbidities, predict functional decline 
over time. Performance on tests of memory and executive function, as well as informant-
reported apathy symptoms, predicted functional disability in a combined longitudinal 
model, indicating that they confer independent effects on daily functioning. 
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Memory 
Declines in episodic memory performance predicted declines in performance of 
complex activities of daily living. On the one hand, this finding is not surprising given 
prior evidence of episodic memory’s cross-sectional associations with everyday 
functioning (e.g., Burdick et al., 2002; Farias et al., 2004, Richardson, Nadler, & Malloy, 
1995). The current results also align with those of Tomaszewski Farias et al. (2009), 
showing a significant relationship between changes in episodic memory and changes in 
IADL performance over time. The current finding that longitudinal episodic memory 
performance independently predicts longitudinal functional decline is discrepant from 
some prior research indicating that changes in episodic memory either are not 
significantly related to functional change (Royall et al., 2005) or that the relationship 
between memory and everyday functioning is moderated by executive functioning (Cahn-
Weiner et al., 2007; Royall et al., 2005; Royall et al., 2007). Differences in the way 
episodic memory was measured may explain these discrepancies. Episodic memory in the 
current study was represented by participant scores on a delayed free recall trial of a 
verbal learning test. Royall et al. (2005) used learning curve on a verbal list learning test 
to represent episodic memory, which represents encoding but not necessarily the 
storage/retrieval aspect of memory that is captured by delayed recall trials. Both Cahn-
Weiner and colleagues (2007) and Tomaszewski- Farias et al. (2009) used composite 
measures of memory performance in their studies; in the former, the composite 
comprised scores from encoding and short delay recall trials of a list learning task, and 
the latter used scores from encoding and long delay recall trials. Thus, significant 
independent longitudinal relationships between episodic memory and IADL performance 
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may be more likely when using delayed recall rather than encoding or immediate recall 
scores: Scores on delayed recall trials may be a better indicator of memory decline than 
encoding or free recall performance.  
It is easy to understand how memory abilities predict IADL performance because 
many of the items on the FAQ require memory skills both prospectively (e.g., 
remembering items that need to be purchased on a shopping trip, remembering 
appointments, remembering the need to pay bills and what needs to be accomplished 
when assembling paperwork) as well as during the execution of tasks (e.g. keeping track 
of current events or the content of TV shows, movies, books and magazines). 
Interestingly, the longitudinal relationship between memory and functional disability did 
not vary across study participants. This suggests that declines in memory predict 
increased functional disability regardless of diagnosis or the magnitude of pre-existing 
cognitive or functional impairment: A change in memory does not precipitate steeper 
functional declines in dementia than it does in MCI or in normal aging. 
Executive Function 
This study also provided evidence for a longitudinal association between 
executive functions and functional abilities, consistent with results from prior research 
showing that executive function longitudinally predicts everyday functioning (Royall et 
al., 2005; Tomaszewski Farias et al., 2009). This finding was expected given that several 
IADLs included in the FAQ seem to require the ability to plan, sequence, and organize 
one’s behavior (preparing a balanced meal, playing a game of skill, traveling, etc.). 
Results from this study further provide additional evidence for the power of Part B of the 
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Trail-Making Test specifically in predicting IADL performance in older adults with and 
without dementia (Bell -McGinty et al., 2002; Burdick et al., 2005; Yeh et al., 2011).  
As with memory, the relationship between executive function and everyday 
functioning did not vary significantly between participants, indicating that declines in 
executive function are associated with similar declines in functional abilities regardless of 
diagnosis. It is possible that the same physiological processes that underline declines in 
executive abilities also drive functional disability. Decreased volume in the orbitofrontal 
cortex, the site of reward and decision-making behaviors, is associated with functional 
impairments in older adults, independent of total brain volume (Taylor et al., 2003). 
Recent research also indicates that hypoperfusion in the right precuneus, part of the 
associative cortex, is associated with declines in performance on both a set-shifting task 
and the FAQ (Chao et al., 2010). 
Neuropsychiatric Symptoms 
Apathy and not depressive symptoms predicted longitudinal declines in daily 
functioning. Longitudinal associations between depressive symptoms and functional 
decline were expected, given prior research documenting relationships between 
depression and poorer daily functioning in persons with cognitive impairment (DeRonchi 
et al., 2005; Fitz & Teri, 1994). One possible reason that depressive symptoms were not 
associated with function in this study is the paucity of depressive symptoms reported for 
participants; informant reports of depressive symptoms were extremely low for all study 
groups, and participants themselves endorsed minimal depressive symptoms. Limited 
variability in depression scores may have made it difficult to discern relationships with 
functional disability. Further, such a low frequency and severity of neuropsychiatric 
 47 
symptoms is unusual for persons with cognitive impairment (Edwards et al., 2009; 
Lyketsos et al., 2002; Steinberg et al., 2008) and also may explain differences from other 
studies.  
This study revealed a significant longitudinal relationship between greater apathy 
and decline in complex activities of daily living despite minimal informant-reported 
apathy symptoms, providing support for the association between this syndrome and 
functional impairment. The current results align with prior research documenting stronger 
associations between apathy and functional disability compared to depression in persons 
with dementia (Clarke et al., 2008; Zawacki et al., 2002) and in amnestic MCI (Zahodne 
& Tremont, 2013). 
Key symptoms of apathy include decreased motivation, initiation, and persistence 
(Ishii et al., 2009), behavioral components that are necessary for task performance. 
Apathy has been related in Alzheimer’s disease patients to impairments in planning, 
initiating and executing IADLs, in contrast to depression, which relates only with 
impaired initiation and planning (Lam et al., 2006). Therefore, it may be that reduced 
desire/drive to persist in and complete tasks accounts for apathy’s particularly negative 
impact on daily functioning. 
Medical Burden 
Results from this study did not support the hypothesis that greater medical burden 
would predict greater functional disability, which suggests that physical health does not 
factor into the performance of complex activities of daily living. These results contradict 
prior findings of significant relationships between poor health and functional disability in 
nursing home and assisted living residents (Burdick et al., 2005; Lyketsos et al., 1999) 
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but align with results from a study of IADL performance in an outpatient Alzheimer’s 
disease sample (Tekin et al., 2001). Methodological differences may underlie these 
contrasting results. First, it is possible that there is greater variability in both physical 
health and functional dependence in persons living in professional facilities than in 
outpatients, which may increase the likelihood of finding a significant relationship 
between medical burden and daily functioning in facility samples. Second, there are 
many ways to operationalize medical burden. This study utilized total medication count 
to represent burden, which has compared favorably to other, more complex assessments 
of medical comorbidity (Perkins et al., 2004). However, medication counts may be less 
sensitive than the health surveys used in other studies that include specific medical 
conditions, such as arthritis, back pain, or a physical disability, that may not require 
medication but that nevertheless impact daily functioning. Third, ADL assessments differ 
across studies. Medical burden may have a stronger association with certain ADLs (i.e., 
traveling out of the neighborhood, grooming and personal hygiene) and less so with 
others (i.e., keeping track of current events), depending on the nature of the task. 
Functional disability questionnaires that include both BADLs and IADLs of the type used 
by Burdick et al. (2005), or that include more IADLs with a physical component, may 
share stronger relationships with medical burden than those that do not. 
Limitations 
The current study has several limitations. First, the study sample overall was high-
functioning. Mean total FAQ score for all groups at baseline was 2.56 out of a possible 
30. There was a floor effect in the FAQ for normal controls and persons with MCI. While 
the dementia groups included persons with a range of cognitive impairment, persons with 
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Alzheimer’s disease and vascular dementia were on average at very mild stages of 
disease based on analysis of baseline CDR scores. As stated previously, minimal levels of 
depressive and apathy symptoms were endorsed by informants for all groups. In addition 
to these generally high levels of emotional and behavioral functioning, the majority of 
study participants were Caucasian, married, and living at home with a spouse or partner. 
They had on average a college education, and many participants had Master’s, 
professional, and doctoral degrees, which could indicate solid cognitive reserve that 
might moderate the outward manifestation of brain pathology (Stern, 2012). For the 
above reasons, results from this study may not generalize to the greater population of 
persons with MCI, Alzheimer’s disease, and vascular dementia. Finally, functional 
performance was measured using a scale that assessed IADLs only and did not include 
BADLs. Therefore, estimates of longitudinal change in daily functioning based on 
memory and executive function performance, and rates of change by baseline diagnosis, 
apply only to higher-level activities and not to basic activities of daily living such as 
eating, bathing, and dressing. 
Conclusions 
Results from this study, while based in an overall high-functioning sample, 
provide evidence that longitudinal memory and executive function performance, as well 
as apathy symptoms independently predict daily functioning. Thus, in terms of cognitive 
abilities, clinicians and caregivers should expect that changes in both memory and 
executive function will correspond with subtle changes in the performance of everyday 
activities. Interestingly, the nature of the relationship between memory and executive 
function declines and functional disability appears to be similar for persons with normal 
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cognitive aging, MCI, and dementia. Therefore, providers should not expect more rapid 
functional decline given a change in cognitive performance in dementia than in MCI. 
With regard to neuropsychiatric symptoms, results indicate that apathy is a potentially 
modifiable predictor of longitudinal functional decline. Future research should address 
whether aggressive psychological and pharmacological treatment can palliate its adverse 
effects on complex daily living activities. Clinicians and caregivers also should expect 
significant and progressive functional decline in persons with MCI and Alzheimer’s 
disease. However, this study suggests that disablement is gradual even in persons with 
Alzheimer’s disease, which may offer some hope to patients and their caregivers. 
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